South Asians Active Together (SAATH) Study

Not Applicable

Completed

• Conditions: South Asian; Physical Inactivity
• Interventions: Behavioral: SAATH Intervention

• Registration Number: NCT04400253
• Lead Sponsor: Northwestern University

Brief Summary

South Asian immigrant women and girls are at increased risk for insufficient physical activity and are not being reached by current approaches to physical activity promotion. This randomized control trial study will test the effectiveness and implementation of a multi component physical activity intervention directed at the environment, family, interpersonal and individual levels to promote physical activity among South Asian immigrant mothers and daughters.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2020-05-11
• Study First Submitted QC: 2020-05-21
• Study First Posted: 2020-05-22
• Study Start: 2020-08-01
• Primary Completion: 2024-03-26
• Study Completion: 2024-03-26
• Status Verified: 2024-11
• Last Update Submitted: 2024-11-19
• Last Update Posted: 2024-11-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 252

Inclusion Criteria

Not provided

Read More

Exclusion Criteria

• having known medical condition that restricts ability to participate in moderate intensity Physical Activity
• Unable to complete study procedures (including not wearing accelerometer during run-in)
• Currently pregnant
• Unable to provide informed consent or assent.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention group	SAATH Intervention	The intervention group will receive a 18-week in-person program. The program includes the following components: multi family group counseling, group exercise classes, mother group discussion, daughter group discussion and Fitbit.

Primary Outcome Measures

Name	Time	Method
Averaged daily minutes spent in moderate- and vigorous-intensity physical activity measured by ActiGraph accelerometers	The outcome will be assessed before the intervention (week 0) and after the intervention (week 18)	Moderate- and vigorous-intensity physical activity will be identified based on the accelerometer count cut-point for moderate intensity and daily minutes spent in moderate- and vigorous-intensity physical activity estimated for seven days will be averaged

Secondary Outcome Measures

Name	Time	Method
Averaged daily minutes spent in walking or running behavior measured by ActiGraph accelerometers	The outcome will be assessed before the intervention (week 0) and after the intervention (week 18)	Walking and running behavior will be recognized using a machine learning activity recognition algorithm and daily minutes spent in walking or running behavior estimated for seven days will be averaged
Self-efficacy score measured by Dishman's Barriers to Self-Efficacy questionnaire	The outcome will be assessed before the intervention (week 0) and after the intervention (week 18)	The self-efficacy score will be calculated by averaging the responses (scored 1 to 5 point; higher scores mean higher self-efficacy \[a better outcome\])
Averaged daily hours spent in sedentary behaviors measured by ActiGraph accelerometers	The outcome will be assessed before the intervention (week 0) and after the intervention (week 18)	Sedentary behaviors will be identified based on the accelerometer count cut-point for sedentary behaviors and daily minutes spent in sedentary behaviors estimated for seven days will be averaged
Systolic and diastolic blood pressure (mmHg) measured by a sphygmomanometer	The outcome will be assessed before the intervention (week 0) and after the intervention (week 18)	Blood pressure will be measured three times while sitting down and relaxing on a chair and the last two measures will be averaged
Self-efficacy score measured by the Exercise Confidence Survey	The outcome will be assessed before the intervention (week 0) and after the intervention (week 18)	The self-efficacy score will be calculated by averaging the responses (scored 1 to 5 point for the responses of strongly disagree to strongly agree) from each question item

Trial Locations

Locations (1)

Northwestern University-Feinberg School of Medicine; 🇺🇸 Chicago, Illinois, United States